JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PGEM
2501
DELISTED
Ply Gem Holdings, Inc.
PGEM
| $3.87M | ﹤0.01% |
215,713
-27,369
| -11% | -$491K |
2013 Q2
16 quarters
|
|
2502
Dine Brands
DIN
$374M
| $3.87M | ﹤0.01% |
87,867
-3,303
| -4% | -$165K |
2013 Q2
16 quarters
|
|
2503
Hurco Companies Inc
HURC
$143M
| $3.85M | ﹤0.01% |
110,911
+1,795
| +2% | +$54.5K |
2013 Q2
16 quarters
|
|
2504
Hackett Group
HCKT
$267M
| $3.85M | ﹤0.01% |
248,371
+121,539
| +96% | +$2.06M |
2015 Q4
6 quarters
|
|
2505
iShares Mortgage Real Estate ETF
REM
$443M
| $3.84M | ﹤0.01% |
82,833
+8,526
| +11% | +$396K |
2016 Q2
4 quarters
|
|
2506
Descartes Systems
DSGX
$6.73B
| $3.84M | ﹤0.01% |
157,544
+117,435
| +293% | +$2.8M |
2015 Q4
6 quarters
|
|
2507
Goodyear
GT
$1.34B
| $3.83M | ﹤0.01% |
109,540
-310,089
| -74% | -$10.7M |
2013 Q2
16 quarters
|
|
|
GNCMA
2508
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $3.83M | ﹤0.01% |
104,543
+81,669
| +357% | +$2.95M |
2015 Q1
9 quarters
|
|
|
BRKL
2509
DELISTED
Brookline Bancorp
BRKL
| $3.83M | ﹤0.01% |
262,139
-160,722
| -38% | -$2.33M |
2015 Q2
8 quarters
|
|
2510
H.B. Fuller
FUL
$2.73B
| $3.82M | ﹤0.01% |
74,801
-54,370
| -42% | -$2.81M |
2014 Q4
10 quarters
|
|
|
CLDT
2511
Chatham Lodging
CLDT
$638M
| $3.82M | ﹤0.01% |
190,256
+82,998
| +77% | +$1.63M |
2013 Q2
16 quarters
|
|
2512
PUT
Oracle
ORCL
$439B
| $3.81M | ﹤0.01% |
76,000
-331,100
| -81% | -$15.1M |
2015 Q3
7 quarters
|
|
2513
CF Industries
CF
$17.6B
| $3.8M | ﹤0.01% |
135,890
-69,751
| -34% | -$1.92M |
2013 Q2
16 quarters
|
|
|
SDRL
2514
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
| $3.79M | ﹤0.01% |
39,304
-4,533
| -10% | -$712K |
2015 Q4
6 quarters
|
|
2515
Argan
AGX
$5.89B
| $3.79M | ﹤0.01% |
63,174
-20,094
| -24% | -$1.3M |
2013 Q2
16 quarters
|
|
2516
CALL
Becton Dickinson
BDX
$49.1B
| $3.79M | ﹤0.01% |
+19,885
| New | +$3.63M |
2017 Q2
0 quarters
|
|
2517
Ingersoll Rand
IR
$30.7B
| $3.78M | ﹤0.01% |
+174,998
| New | +$3.91M |
2017 Q2
0 quarters
|
|
|
S
2518
DELISTED
Sprint Corporation
S
| $3.77M | ﹤0.01% |
459,634
-1,120,124
| -71% | -$9.31M |
2013 Q3
15 quarters
|
|
2519
ScottsMiracle-Gro
SMG
$2.94B
| $3.77M | ﹤0.01% |
42,153
-94,121
| -69% | -$8.49M |
2013 Q2
16 quarters
|
|
2520
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.57B
| $3.77M | ﹤0.01% |
70,850
-4,171
| -6% | -$218K |
2013 Q2
16 quarters
|
|
2521
CytomX Therapeutics
CTMX
$558M
| $3.76M | ﹤0.01% |
242,750
+56,972
| +31% | +$859K |
2016 Q4
2 quarters
|
|
|
SVU
2522
DELISTED
SUPERVALU Inc.
SVU
| $3.75M | ﹤0.01% |
162,897
+991
| +0.6% | +$26.4K |
2013 Q2
16 quarters
|
|
2523
Woodward
WWD
$19.6B
| $3.75M | ﹤0.01% |
55,434
-58,011
| -51% | -$3.96M |
2016 Q4
2 quarters
|
|
2524
Healthcare Services Group
HCSG
$1.45B
| $3.75M | ﹤0.01% |
79,985
-67,715
| -46% | -$3.13M |
2013 Q2
16 quarters
|
|
|
RARX
2525
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $3.75M | ﹤0.01% |
199,900
+50,432
| +34% | +$1.14M |
2016 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.